FNY Partners Fund’s vTv Therapeutics VTVT Stock Holding History

FNY Partners Fund’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-31	Closed	-$7K	–	1162
2017 Q1	$7K	Buy	+31	New	+$7.07K	﹤0.01%	1153

Other funds holding VTVT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FNY Partners Fund's VTVT Position: Q2 2017 in Review

FNY Partners Fund sold out of vTv Therapeutics (VTVT) in Q2 2017, closing a stake of 31 shares — an estimated $7K sold.

FNY Partners Fund first reported a position in VTVT in Q1 2017 and held it in 1 quarter. The position peaked at $7K in Q1 2017. 39 funds tracked by Wall St. Rank hold VTVT as of Q2 2017.

FNY Partners Fund reported no remaining vTv Therapeutics position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 31 vTv Therapeutics shares in Q2 2017, an estimated $7K.
FNY Partners Fund first reported a position in vTv Therapeutics in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's vTv Therapeutics position peaked at $7K in Q1 2017.
39 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.